Delivery Order HHSN272201600009I-75N93019F00131

Award Date 8/1/19
Potential Completion Date 7/31/22
Potential Value $537K
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $486,301.00 cost-plus-fixed-fee delivery order contract to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization. Under this contract, the Lovelace Biomedical Research Institute will perform the transfer, validation, and qualification of bioanalytical methods for the detection of cabotegravir and levonorgestrel in rat and nonhuman primate plasma. This work is being conducted...
The Lovelace Biomedical Research Institute was awarded a $18,397 cost plus fixed fee delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Lovelace to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $716,374 delivery order contract to Lovelace Biomedical Research Institute. Under the terms of the firm fixed price contract, Lovelace Biomedical Research Institute will conduct a Good Laboratory Practice repeat dose toxicology study for BPL-24910 in support of the Comprehensive and Rapid Response for NIAID Research Programs major program code. Performance...
This is a task order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The task order, titled "PRE-CLINICAL MODELS OF INFECTIOUS DISEASES TASK ORDER B07", is part of NIAID's Preclinical Models of Infectious Diseases contract vehicle, which provides...
This delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' Preclinical Services for HIV Therapeutics master IDIQ contract funds the guaranteed minimum amount of $0.00 to Lovelace Biomedical and Environmental Research Institute, Inc. for preclinical services supporting HIV therapeutics research. Performance will occur in Albuquerque, New Mexico. The prime contractor, Lovelace Biomedical and...
This is a $498,476.00 federal Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Southern Research Institute, a non-profit research organization. The contract is for a pharmacokinetics study of the long-acting HIV therapeutic drug candidate Telacebec (Q203) in Sprague Dawley rats. This Delivery Order is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract...
This is a $4,711,752.76 cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The order is part of the Biomedical Advanced Research and Development Authority's (BARDA) Biological Animal Model Development 2017-2022 contract vehicle and involves the development of animal models for evaluating medical countermeasures against...
This is a $403,478.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization. The contract is for conducting hit-to-lead progression studies on investigational agents for the treatment of HIV. This work will be performed under NIAID's Preclinical Services for HIV Therapeutics indefinite...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $520,896.73 contract is for the evaluation of drug efficacy in a rat model of neuropathic pain. Lovelace Biomedical Research Institute has experience conducting animal studies, including for federal...
This is a $3,108,022.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA) to the Lovelace Biomedical Research Institute, a non-profit preclinical contract research organization. The contract is for the characterization of a downstream gene therapeutic for the reparative treatment of severe fractures, with a period of performance from September 24, 2020 to November 23, 2021. This contract does not have a set-aside designation. Lovelace Biomedical...

This $537,319.27 federal delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract supports the TRANSFER AND VALIDATION OF BIOANALYTICAL METHOD FOR DETECTION OF CABOTEGRAVIR IN RAT PLASMA under NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. This work is being performed as a task order under NIAID's HIV Microbicides and Biomedical Prevention 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute leverages over 70 years of expertise in areas like inhalation toxicology, infectious disease modeling, and medical countermeasure testing to conduct nonclinical animal studies for government agencies across the drug development lifecycle.

Generated 1/15/25, 9:23 AM